No Prescription |
 |
 | ||
|
OKAMET Fortamet |
|
| ||
No Prescription » Prescription Drugs 12 » OKAMET Fortamet Metformin is used alone or with other medications including insulin to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) . Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. Metformin also increases your body's response to insulin a natural substance that controls the amount of glucose in the blood. Metformin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood).Metformin comes as a tablet and an extended-release (long-acting) tablet to take by mouth. The regular tablet is usually taken with meals two or three times a day. The extended-release tablet is usually taken once daily with the evening meal. To help you remember to take metformin take it around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take metformin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow metformin extended-release tablets whole; do not split chew or crush them.Your doctor may start you on a low dose of metformin and gradually increase your dose not more often than once every 1-2 weeks. You will need to monitor your blood sugar carefully so your doctor will be able to tell how well metformin is working. Buy OKAMET Fortamet and other Prescription Drugs 12 products online at Medstore. 722
About OKAMET Fortamet: Product Type: Prescription Drugs 12 OKAMET ( Fortamet Glucophage Glucophage XR Riomet Glumetza Generic Metformin ) OKAMET (Fortamet Glucophage Glucophage XR Riomet Glumetza Generic Metformin) Fortamet Glucophage Glucophage XR Riomet Glumetza Generic Metformin 500mg Tabs 100 (10 x 10) Fortamet Glucophage Glucophage XR Riomet Glumetza Generic Metformin OKAMET
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
